You can find the annual or quarterly income statement of MapLight Therapeutics Inc here for insights into the performance and operational efficiency of MapLight Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Operating expenses

--64.50M

--83.38M

R&D expenses

--59.10M

--64.62M

Depreciation, depletion, and amortization

--162.00K

----

Operating profit

---64.50M

---83.38M

Net non-operating interest income (expenses)

Non-operating interest income

--2.47M

Return on equity

----

--0.00

Other non-operating income (expenses)

--1.36M

Net income from continuous operations

---60.67M

---79.55M

Net income attributable to controlling interests

---60.67M

---79.55M

Net income attributable to common shareholders

---60.67M

---79.55M

Basic earnings per share

---1.34

----

Diluted earnings per share

---1.34

----

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

